[Pityriasis rubra pilaris : Successful treatment with ixekizumab]

Hautarzt. 2020 Aug;71(8):624-626. doi: 10.1007/s00105-020-04575-6.
[Article in German]

Abstract

Pityriasis rubra pilaris is a rare papulosquamous chronic skin disease. The disease often exists for years and is difficult to treat. Not only is it clinically similar to psoriasis vulgaris, but both diseases also have a similar cytokine profile. The successful use of biologicals is frequently reported in case reports. Studies with large numbers of cases are lacking.

Keywords: Biological therapy; Cytokine profile; Interleukin-17A inhibitor; Off-label use; Skin diseases, papulosquamous.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Dermatologic Agents / therapeutic use*
  • Humans
  • Pityriasis Rubra Pilaris / drug therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • ixekizumab